The epidemiology of apnoea of prematurity.
Joseph V PergolizziPrem FortThomas L MillerJo Ann LeQuangRobert B RaffaPublished in: Journal of clinical pharmacy and therapeutics (2022)
Attempts to elucidate the epidemiology of apnoea of prematurity have been challenging. Studies of AOP are hampered in part by challenges in monitoring the condition, the interplay of multiple comorbidities in preterm neonates and lack of expert consensus definitions. However, since the primary risk factor is preterm birth, efforts to decrease the prevalence of preterm birth would have a positive secondary effect on the prevalence of AOP. Until then, better pharmacotherapeutic options are needed.